The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent ...
It's the latest defeat for allies of Donald Trump seeking to change how the battleground state's votes are counted in the Nov. 5 presidential election.